Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Our Products
MouseAtlas
iPSC Cell Lines
Knockout Cell Lines
Tumor Cell Lines
Adeno-associated Virus (AAV) Standard Capsid
Featured Catalog
Humanized Mouse Models
HUGO-GT™
HUGO-Ab™
Humanized Target Gene Models
Humanized Immune System Mouse Models
Tool Mice
Cre Mouse Lines
Disease Models
Autoimmune Disease Models
Ophthalmic Disease Models
Immunodeficient Mouse Models
Metabolic Disease Models
Neurological Disease Models
Oncology & Immuno-oncology Models
Services
Model Generation Techniques
Turboknockoutᵀᴹ Gene Targeting
Cre-ESCs Gene Editing
Targeted Gene Editing
Genetically Engineered Animals
Knockin Mice
Knockin Rats
Knockout Mice
Knockout Rats
Transgenic Mice
Transgenic Rats
Transgenic Model Generation
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Adenovirus Packaging
Lentivirus Packaging
Custom Cell Line Services
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Overexpression Cell Lines
Point Mutation Cell Lines
Breeding & Supporting Services
BAC Modification
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
Drug Discovery and Development
Antibody Discovery Platform
HUGO-Ab™
HUGO-Mab™
HUGO-Light™
HUGO-Nano™
HUGO-Ab-eKO™
Therapeutic Area
Neurology
Alzheimer's Disease (AD)
Parkinson's Disease (PD)
Huntington's Disease (HD)
Blood Brain Barrier (BBB)
Neuropathic Pain
Metabolic & Cardiovascular
Obesity
Ophthalmology
Glaucoma
Age-Related Macular Degeneration (AMD)
Oncology
PBMC Humanized Mouse Model
Human Immune System (HIS) Mouse Model
Immunology & Inflammation
Asthma
Innovative Drug R&D
Therapeutic Antibody Drugs
Monoclonal Antibodies (mAb)
Bispecific Antibodies (BsAb)
ADC/AOC
AI-Powered AAV Discovery
Cell Immunotherapy
Gene Therapy
Oligonucleotide Therapy
Fully Human Antibody Library
Neurology Antibodies
Metabolic & Cardiovascular Antibodies
Ophthalmology Antibodies
Oncology Antibodies
Immunology & Inflammation Antibodies
Resources
News
Blogs & Insight
Promotion
Events & Webinars
Databases
AbSeek
Rare Disease Data Center
Cell iGeneEditor™ System
Citations
Resource Vault
OriCell
About Us
Animal Health & Welfare
Corporate Overview
Facility Overview
Our Team
Our Partners
Careers
Health Reports
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Catalog Type
Product Name
Quantity
Main Area of Research
Additional Comments
How did you hear about us?
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.

Search for Cyagen Tumor Cell Lines

ACHN
GL261
H22
B16
CT26.WT
View all models >>
Modification Type
Cancer Type
Species
Host Strain
CYTC00001
Cell Line
5637
Species
Human
Cancer Type
Bladder cancer
Modification Type
Wild-type cells
Host Strain
NKG
Tumor Model Type
Subcutaneous model
Cell Line Status:
Successin vivo Tumorigenicity
Order >>
CYTC00002
Cell Line
5637-luc
Species
Human
Cancer Type
Bladder cancer
Modification Type
Luciferase cells
Host Strain
NKG
Tumor Model Type
Subcutaneous model, Orthotopic model
Cell Line Status:
SuccessConstruction
SuccessExpression Validation
Successin vivo Tumorigenicity
Order >>
CYTC00003
Cell Line
RT-4
Species
Human
Cancer Type
Bladder cancer
Modification Type
Wild-type cells
Host Strain
NKG
Tumor Model Type
Subcutaneous model
Cell Line Status:
Successin vivo Tumorigenicity
SuccessDrug Efficacy Cases
Order >>
CYTC00004
Cell Line
SW780
Species
Human
Cancer Type
Bladder cancer
Modification Type
Wild-type cells
Host Strain
NKG
Tumor Model Type
Subcutaneous model
Cell Line Status:
Successin vivo Tumorigenicity
Order >>
CYTC00005
Cell Line
UM-UC-3
Species
Human
Cancer Type
Bladder cancer
Modification Type
Wild-type cells
Host Strain
NKG，BALB/c nude
Tumor Model Type
Subcutaneous model
Cell Line Status:
Successin vivo Tumorigenicity
Order >>
CYTC00006
Cell Line
BT-474
Species
Human
Cancer Type
Breast cancer
Modification Type
Wild-type cells
Host Strain
NKG，NOD-Scid
Tumor Model Type
Subcutaneous model
Cell Line Status:
Successin vivo Tumorigenicity
Order >>
CYTC00007
Cell Line
HCC1086
Species
Human
Cancer Type
Breast cancer
Modification Type
Wild-type cells
Host Strain
NKG，BALB/c nude
Tumor Model Type
Subcutaneous model
Cell Line Status:
Successin vivo Tumorigenicity
SuccessDrug Efficacy Cases
Order >>
CYTC00008
Cell Line
MCF-7
Species
Human
Cancer Type
Breast cancer
Modification Type
Wild-type cells
Host Strain
NKG
Tumor Model Type
Subcutaneous model
Cell Line Status:
Successin vivo Tumorigenicity
Order >>
CYTC00009
Cell Line
MCF-7-luc
Species
Human
Cancer Type
Breast cancer
Modification Type
Luciferase cells
Host Strain
NKG
Tumor Model Type
Subcutaneous model，Bone metastasis
Cell Line Status:
SuccessConstruction
SuccessExpression Validation
Successin vivo Tumorigenicity
Order >>
CYTC00010
Cell Line
MDA-MB-231
Species
Human
Cancer Type
Breast cancer
Modification Type
Wild-type cells
Host Strain
NKG，NOD-Scid
Tumor Model Type
Subcutaneous model
Cell Line Status:
Successin vivo Tumorigenicity
Order >>
Items: 1 to 10 of 106
1
2
3
4
5
6
...
10
11
More
Order
Can’t find the cell line you need?
Explore our  Custom Cell Line Services  to create exactly what you need.
Request a Custom Cell Line Consultation
Tell us about your cell line project needs. Our specialists are ready to support your research with tailored solutions.
Inquiry Details
Main Area of Research
Service(s) of Interest
Gene of Interest
Project Details
How did you hear about us?
Contact Information
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our  Privacy Policy  for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0336
Email:
inquiry@cyagen.com
Services
HUGO-GT™HUGO-Ab™iPSC Cell LinesAdeno-associated Virus (AAV) Standard Capsid
Drug R&D
NeurologyMetabolicOphthalmologyOncology
About Us
Animal Health & WelfareCorporate OverviewOur TeamHealth Reports
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Global Antibody Drug Industry Development BlueBook (Frost & Sullivan)
Key Insights
The industry is undergoing a rapid transformation driven by next-generation modalities, globalized markets, and upstream technological innovations.
  • Market Structural Shift: Monoclonal antibodies drive steady growth, but ADCs and bispecifics are rapidly accelerating, reshaping the market with higher-value innovations.
  • Chinese Market Globalization: China is actively expanding globally, evidenced by a surge in high-value cross-border license-out deals.
  • Technology-Driven Efficiency: Advanced discovery engines—exemplified by Cyagen's HUGO-Ab platform and AI algorithms—are streamlining candidate screening, optimizing molecular design, and localizing the upstream supply chain.
  • Oncology-Focused Innovation: R&D pipelines remain heavily concentrated on high-incidence malignancies like non-small cell lung cancer, utilizing complex modalities to combat clinical resistance.
Now Available for Download
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest
Main Area of Research